Therapeutics II: Exam 1 - IBD (UC and CD) RW

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/107

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

108 Terms

1
New cards

What is IBD?

Generic term for series of chronic inflammatory conditions of the GI tract

2
New cards

What 2 conditions are most common with IBD?

Ulcerative Colitis (UC)

Chron's Disease (CD)

3
New cards

At what ages does IBD most commonly occur?

Peaks between ages 14 and 30

4
New cards

In what patients is IBD more common?

More common with European ancestry, white race, and urban dwellers

Occurs in familiar clusters

5
New cards

What is the relationship between NSAIDs and IBD?

NSAIDs can exacerbate IBD

Also a risk factor for development of IBD

6
New cards

What is the relationship between smoking and IBD?

Smoking is a NEGATIVE risk factor for UC

But it INCREASES the severity of CD

7
New cards

What are possible extraintestinal complications of IBD?

Acute arthropathy

Erythema nodosum

Pyoderma gangrenosum

Iritis/uveitis

Ankylosing spondylitis

Primary sclerosing cholangitis

“Metastatic” CD

8
New cards

How are extraintestinal complications of IBD treated?

Treating the luminal disease will usually resolve other problems

Must catch before irreversible damage occurs

9
New cards

What is the general treatment strategy for IBD?

Induction therapy in pt.'s with active disease

Maintenance therapy to prevent recurrence of symptoms

Target therapy to site of disease

10
New cards

How should therapy for IBD be dosed?

"Top Down Approach"

Hit hard with biologics immediately to heal mucosa and trigger remission

MAY be able to taper off over time and achieve long term remission

Continuous treatment with biologics results in better outcomes than episodic treatment

11
New cards

What areas are affected by UC?

Limited to colon and rectum

12
New cards

What causes symptoms in UC?

Shallow ulcers lining continuous sections of the large intestine

13
New cards

What symptoms are seen w/UC?

Chronic loose and bloody stools (hallmark)

Tenesmus

Abd. pain

14
New cards

What is the depth of inflammation in UC?

Superficial

15
New cards

What is described by mild UC?

<4 stools/day

No systemic signs of toxicity

Normal ESR

16
New cards

What is described by moderate UC?

6-10 bloody stools/day

Abdominal pain, but can eat

Positive fecal calprotectin (FCP)

17
New cards

What is described by severe UC?

>10 bloody stools/day

Fever

Tachycardia

Anemia

Positive CRP and FCP

18
New cards

What induction therapy should be used for UC proctitis, of any severity?

5-ASA suppository

19
New cards

What remission therapy should be used for UC proctitis, of any severity?

Continue 5-ASA suppository

20
New cards

If therapy for UC proctitis, of any severity, is not effective what should be used?

Use oral 5-ASA

21
New cards

What induction therapy should be used for UC mild to moderate distal colitis?

5-ASA enema

22
New cards

What remission therapy should be used for UC mild to moderate distal colitis?

Continue 5-ASA enema

23
New cards

If therapy for UC mild to moderate distal colitis, is not effective what should be used?

Use oral 5-ASA

24
New cards

What induction therapy should be used for UC severe distal colitis?

5-ASA Enema

PLUS oral 5-ASA OR budesonide

25
New cards

What remission therapy should be used for UC severe distal colitis?

5-ASA enema PLUS oral 5-ASA

26
New cards

If therapy for UC severe distal colitis, is not effective what should be used?

Treat as pancolitis

Oral 5-ASA or thiopurines for remission

27
New cards

What induction therapy should be used for UC mild to moderate pancolitis?

Oral 5-ASA or Budesonide

28
New cards

What remission therapy should be used for UC mild to moderate pancolitis?

Oral 5-ASA

29
New cards

If therapy for UC mild to moderate pancolitis, is not effective what should be used?

Treat as severe disease

Oral or IV steroids to induce

Thiopurines for remission

30
New cards

What induction therapy should be used for UC severe pancolitis?

Oral or IV steroids

31
New cards

What remission therapy should be used for UC severe pancolitis?

Thiopurines

32
New cards

If therapy for UC severe pancolitis, is not effective what should be used?

Consider early biologics if severe disease on colonoscopy

33
New cards

What induction therapy should be used for UC pancolitis that is not responsive to non-biologic therapy?

Anti-TNF therapy (preferred), or

S1P Modulators, or

IL 12/23 blockers, or

Vedolizumab, or

JAK-inhibitors

34
New cards

What remission therapy should be used for UC pancolitis that is not responsive to non-biologic therapy?

Continue biologic tx.

35
New cards

How does CD manifest?

Focal, asymmetric, transmural, and occasionally granulomatous inflammation affecting the GI tract

36
New cards

What areas are affected by CD?

Can affect ANY part of GI tract (from mouth to anus)

37
New cards

What is the depth of inflammation in CD?

Transmural

38
New cards

What are symptoms of CD?

Diarrhea, usually severe with nocturnal episodes

Abdominal pain and tenderness

Weight loss

Fever

Nausea

Anorexia

39
New cards

What complications are associated with CD?

Ulcers

Fistulas

Abscesses

Intestinal blockage

Extra-intestinal disorders (more common w/CD)

Malnutrition

Growth failure in children

40
New cards

What are fistulas?

Tunnel between 2 sections of intestines, or between intestine and other organs

Very painful

Source of infection

41
New cards

What is described by mild-moderate CD?

Ambulatory patients

Able to tolerate oral feedings

No signs of systemic toxicity

42
New cards

What is described by moderate-severe CD?

Fever,

Weight loss,

Abdominal pain,

Nausea and vomiting, and/or

Significant anemia

43
New cards

What is described by severe-fulminant CD?

Patients with persistent symptoms despite standards induction regimens

Or, those with signs of severe systemic toxicity

44
New cards

What is recommended for induction therapy in mild to moderate CD?

Oral steroids

5-ASA

Enteral nutrition

45
New cards

What is recommended for induction therapy in moderate to severe CD?

Oral steroids

Enteral nutrition

46
New cards

What is recommended for induction therapy in severe to fulminant CD?

IV steroids

IV nutrition

47
New cards

If a patient is steroid refractory, what should be used for CD treatment?

Anti-TNF, Ustekinumab, or Vedolizumab

48
New cards

If a patient is steroid dependent, what should be used for CD treatment?

Thiopurine (AZA or 6-MP); OR

Biologic (Anti-TNF, Ustekinumab, or Vedolizumab)

49
New cards

If a patient is achieves response/remission after induction, what should be used for CD treatment?

Maintain remission

50
New cards

If a patient has perforation, bleeding, obstruction, abscess, refractory lesions, or cancer what should be done for CD treatment?

Surgery

51
New cards

What agents are options for induction of mild to moderate CD?

Mesalamine only if have mild colonic CD

Budesonide

52
New cards

What agents are options for induction of moderate to severe CD?

Oral corticosteroids

Anti-TNF agents (also for maintenance)

Vedolizumab (also for maintenance)

Il 12/23 agents - Ustekinumab (also for maintenance)

Upadacitinib (also for maintenance)

53
New cards

What agents are options for maintenance of moderate to severe CD?

Thiopurines

Methotrexate

Anti-TNF agents (also for induction)

Vedolizumab (also for induction)

Il 12/23 agents - Ustekinumab (also for induction)

Upadacitinib (also for induction)

54
New cards

What agents are options for fistulizing CD?

TNF agents - infliximab, adalimumab, and golimumab

55
New cards

What agents are options for fulminant CD?

IV corticosteroids or TNF agents

56
New cards

What agents are considered for use in pregnancy?

Aminosalicylates

Thiopurines

Biologics (esp. TNFi's)

Induce and maintain remission for 3-6 months before delivery

57
New cards

When are 5-ASA suppositories indicated?

Proctitis treatment

58
New cards

When are 5-ASA enemas indicated?

IBD confined to distal colon

59
New cards

What ADRs are associated with sulfasalazine?

Fever

Rash

Nausea

BMS

60
New cards

What ADRs are associated with mesalamine?

Fewer ADRs than sulfasalazine

Headache, arthralgias, abdominal pain, and nausea can occur

Olsalazine preparation causes more diarrhea

Balsalazide preparation can inc. 6-MP/AZA levels

61
New cards

What is the use of methotrexate in IBD?

Can be used for maintaining remission of CD

62
New cards

What is budesonide?

Corticosteroid

High first-pass effect and low bioavailability

Delivered directly to colon

63
New cards

What is budesonide used for in IBD?

Standard treatment for induction of mild/moderate ileocolonic disease

64
New cards

What is the advantage of using budesonide instead of other oral steroids?

Fewer short-term ADRs than traditional steroids

65
New cards

What are the names of the thiopurines?

6-Mercaptopurine (6-MP)

Azathioprine (AZA)

66
New cards

What are the thiopurines used for in IBD?

Standard agents for maintenance therapy in moderate-to-severe IBD

67
New cards

What is the onset of action of the thiopurines?

Onset of action is usually weeks to 3 months

Often require steroid use short-term

68
New cards

What ADRs are associated with the thiopurines?

Rash

Nausea

Pancreatitis

Diarrhea

Myelosuppression/neutropenia

69
New cards

What monitoring is recommended for the thiopurines?

Monitor the CBC for the first 3 months of treatment, then every 3 months thereafter

Signs of pancreatitis (look for epigastric pain and an increased serum lipase)

70
New cards

What pharmacogenomic testing is recommended for the thiopurines?

TPMT activity

LOW TPMT levels = increased risk for neutropenia

HIGH TPMT levels = decreased efficacy

71
New cards

What are the names of the TNF inhibitors?

Infliximab

Adalimumab

Certolizumab

Golimumab

72
New cards

What is the MOA of the TNF inhibitors?

Block tumor Necrosis Factor-a

Which is responsible for much of the pro-inflammatory response in IBD

73
New cards

Can the TNF inhibitors be used in UC and/or CD?

Both - UC and CD

74
New cards

How are the TNF inhibitors administered?

IV or SubQ

75
New cards

What ADRs/Precautions are associated with the TNF inhibitors?

Infection

Infusion reactions

Autoimmune arthritis

Slight inc. risk lymphoma

76
New cards

When are the TNF inhibitors C/I?

C/I in CHF or autoimmune neurologic conditions

C/I in anyone with an active bacterial infection or in patients with a history of chronic infection

77
New cards

How should patients be screened prior to initiating therapy with TNF inhibitors?

PPD screen for TB

Screening for Hep B/C

Assess vaccination status before starting

78
New cards

What monitoring is recommended for TNF inhibitor therapy?

TDM (drug conc. and anti-drug Ab's)

Signs of infection

79
New cards

What are the names of the α4β7 Integrin Blockers?

Natalizumab

Vedolizumab

80
New cards

What is the MOA of Vedolizumab (α4β7 Integrin Blocker)?

Block inflammatory pathway in gut and brain

81
New cards

What is the main difference between Natalizumab and Vedolizumab?

Natalizumab implicated in reactivating JC virus in brain, causing PML

Vedolizumab does not penetrate BBB

82
New cards

Can the Vedolizumab be used in UC and/or CD?

Both - UC and CD

83
New cards

How is Vedolizumab administered?

SubQ

84
New cards

What ADRs/Precautions are associated with Vedolizumab

Infection

(Does NOT penetrate BBB)

85
New cards

What are the names of the IL-12/23 drugs?

Ustekinumab

Guselkumab

Mirikizumab

Risankizumab

86
New cards

What is the MOA of ustekinumab?

Inhibits IL-12 and IL-23

Key cytokines in the pathogenic immune cascade of CD

Inhibits IL-12 and IL-23-mediated signaling, cellular activation, and downstream cytokine production

87
New cards

When is ustekinumab (Il-12/23) used in IBD?

Induction/maintenance therapy for moderate to severe CD

Usually in patients failing TNF drugs

88
New cards

Can the IL-12/23 drugs (Ustekinumab) be used in UC and/or CD?

Both - UC and CD

89
New cards

How are the IL-12/23 (Ustekinumab) drugs administered?

SubQ

90
New cards

What ADRs/Precautions are associated with the IL-12/23 drugs (Ustekinumab)?

Infection

Hep B increase risk

91
New cards

What are the names of the JAK inhibitors?

Tofacitinib

Upadacitinib

92
New cards

Can the JAK inhibitors be used in UC and/or CD?

Only UC

93
New cards

How are the JAK inhibitors administered?

Oral

94
New cards

What ADRs/Precautions are associated with the JAK inhibitors?

Infection

Shingles reactivation

Increased LDL

95
New cards

When are the JAK inhibitors C/I?

C/I in CAD or pt.'s over 65

96
New cards

What are the names of the S1PR modulators?

Ozanimod

Etrasimod

97
New cards

Can the S1PR modulators (-mod's) be used in UC and/or CD?

Only UC

98
New cards

How are the S1PR modulators (-mod's) administered?

Oral

99
New cards

What ADRs/Precautions are associated with the S1PR modulators (-mod's)?

Bradycardia

Increased LFT's

100
New cards

What treatment(s) has an absolute or relative C/I in pt.'s with latent TB?

Anti-TNF

(can treat TB and then start)